Kenneth R McCurry

Author PubWeight™ 71.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006 3.16
2 Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int 2009 2.35
3 Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant 2004 2.09
4 Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant 2009 1.78
5 Striving for normalcy: symptoms and the threat of rejection after lung transplantation. Soc Sci Med 2004 1.56
6 HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant 2005 1.46
7 Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J 2012 1.43
8 Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 2003 1.43
9 Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 2009 1.34
10 Therapeutic antioxidant medical gas. J Clin Biochem Nutr 2008 1.29
11 Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003 1.28
12 HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant 2004 1.27
13 Adherence to the medical regimen during the first two years after lung transplantation. Transplantation 2008 1.26
14 Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clin Transplant 2009 1.24
15 Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2006 1.23
16 Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 2007 1.21
17 Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 2009 1.17
18 Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004 1.14
19 Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2006 1.12
20 Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant 2009 1.12
21 Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts. Kidney Int 2008 1.09
22 Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen. Antimicrob Agents Chemother 2006 1.06
23 Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008 1.05
24 Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006 1.03
25 Avoidant coping with health problems is related to poorer quality of life among lung transplant candidates. Prog Transplant 2003 1.02
26 Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Transplantation 2009 1.01
27 Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007 1.01
28 Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant 2005 1.00
29 Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung 2004 0.99
30 Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007 0.98
31 Low-dose carbon monoxide inhalation prevents ischemia/reperfusion injury of transplanted rat lung grafts. Surgery 2006 0.98
32 Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival. Ann Thorac Surg 2009 0.98
33 Subclavian insertion of the bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg 2012 0.96
34 Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 2003 0.94
35 Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J Clin Biochem Nutr 2008 0.89
36 Plasma inflammatory mediators associated with bone metabolism in COPD. COPD 2010 0.89
37 Quality of life and coping strategies among lung transplant candidates and their family caregivers. Soc Sci Med 2004 0.88
38 Experimental orthotopic lung transplantation model in rats with cold storage. Surg Today 2009 0.87
39 Early tracheostomy is associated with improved outcomes in patients who require prolonged mechanical ventilation after cardiac surgery. J Am Coll Surg 2012 0.87
40 Prior cardiac surgery is not a contraindication for lung donor. Ann Thorac Surg 2007 0.87
41 Antibody-mediated rejection in lung transplantation: case reports. Clin Transpl 2006 0.87
42 Pattern and predictors of early rejection after lung transplantation. Am J Crit Care 2003 0.87
43 Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts. Cardiovasc Res 2010 0.86
44 Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2008 0.86
45 Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury. Curr Cardiol Rev 2009 0.85
46 Increased lung allograft failure in patients with HLA-specific antibody. Clin Transpl 2007 0.83
47 Orally administered nitrite attenuates cardiac allograft rejection in rats. Surgery 2009 0.83
48 Preservation solution supplemented with biliverdin prevents lung cold ischaemia/reperfusion injury. Eur J Cardiothorac Surg 2012 0.83
49 Five-year outcomes with alemtuzumab induction after lung transplantation. J Heart Lung Transplant 2011 0.82
50 Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts. Transplantation 2008 0.81
51 Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. Biochem Biophys Res Commun 2008 0.81
52 Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury. J Thorac Cardiovasc Surg 2012 0.81
53 Simkania negevensis in bronchoalveolar lavage of lung transplant recipients: a possible association with acute rejection. Transplantation 2007 0.81
54 Personality characteristics among cardiothoracic transplant recipients. Gen Hosp Psychiatry 2005 0.80
55 P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection. Transplantation 2004 0.80
56 Surgical revascularization for cardiac allograft vasculopathy: Is it still an option? J Thorac Cardiovasc Surg 2009 0.79
57 Predictors of acute rejection after lung transplantation. Ann Thorac Surg 2011 0.79
58 Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients. Transplantation 2010 0.78
59 Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg 2011 0.78
60 Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect 2006 0.78
61 Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation 2009 0.78
62 Comparative study of bronchial artery revascularization in lung transplantation. J Thorac Cardiovasc Surg 2013 0.78
63 Impact of abdominal complications on outcome after mechanical circulatory support. Ann Thorac Surg 2010 0.77
64 Elevated CXCL10 (IP-10) in bronchoalveolar lavage fluid is associated with acute cellular rejection after human lung transplantation. Transplantation 2014 0.77
65 3D-multidetector CT angiography in the evaluation of potential donors for living donor lung transplantation. J Thorac Imaging 2005 0.77
66 Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Transplantation 2009 0.76
67 Use of endobronchial valves for native lung hyperinflation associated with respiratory failure in a single-lung transplant recipient for emphysema. Chest 2007 0.76
68 Recipient hyperbilirubinaemia protects cardiac graft in rat heterotopic heart transplantation. Eur J Cardiothorac Surg 2013 0.76
69 Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant 2008 0.76
70 Lung and heart-lung transplantation at the University of Pittsburgh: 1982-2002. Clin Transpl 2002 0.75
71 Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation. Anesth Analg 2016 0.75
72 Does simultaneous lung-liver transplantation provide an immunologic advantage compared with isolated lung transplantation? J Thorac Cardiovasc Surg 2011 0.75
73 Variability in Pressure of Arterial Oxygen to Fractional Inspired Oxygen Concentration Ratio During Cellular Ex Vivo Lung Perfusion: Implication for Decision Making. Transplantation 2015 0.75
74 Accessory mitral valve associated with mitral cleft, bicuspid aortic valve, and aortic coarctation. J Am Coll Cardiol 2010 0.75